切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - MAGL - Inward Rectifier Potassium (Kir) Channels - Acetylcholine - Cdc7

10 件产品

每页
清除全部
  1. Cisatracurium Besylate
    B1355 Cisatracurium Besylate
    中文名: 顺苯磺阿曲库铵
    Target: Acetylcholine
    Summary: 神经肌肉阻滞药
      ≥62.17 mg/mL
      ≥24.7 mg/mL
  2. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  3. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  4. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  5. XL413
    B1232 XL413
    Target: Cdc7
    Summary: Cdc7抑制剂
      Soluble in DMSO
  6. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  7. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  8. PHA-767491
    A3721 PHA-767491
    Target: Cyclin-Dependent Kinases|MK2|Cdc7
    Summary: Cdc7 / CDK9抑制剂
      ≥10.65 mg/mL
      insoluble in H2O
  9. Glimepiride
    A4033 Glimepiride
    中文名: 格列美脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 磺酰脲类化合物
      ≥21.45 mg/mL
      insoluble in H2O
  10. Tanshinone IIA
    N1846 Tanshinone IIA
    中文名: 丹参酮IIA
    Target: AP-1|MAGL
    Summary: 抗氧化和抗炎剂
      ≥3.42 mg/mL
      insoluble in H2O

10 件产品

每页